2 completed, 1 recruiting, 1 unknown. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow AL3818: new trials by email Literature Review of AL3818 trials Research Report on AL3818
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) AL3818, Dacarbazine, AL3818 or placebo - Alveolar Soft Part Sarcoma, Leiomyosarcoma | Phase 3 | Recruiting | Advenchen Laboratories, LLC | 325 | 2017-08-15 | 2026-02-25 |
| Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) AL3818, Paclitaxel, Pegylated Liposomal Doxorubicin (PLD) - Endometrial Carcinoma, Ovarian Carcinoma | Phase 3 | Unknown | Advenchen Laboratories, LLC | 294 | 2015-12-01 | 2023-11-08 |
| Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0303) Anlotinib, Placebo - Non-small Cell Lung Cancer | Phase 2 / Phase 3 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 439 | 2015-02-26 | 2017-09-18 |
| Study of Anlotinib in Patients With Metastatic Colorectal Cancer(mCRC)(ALTER0703) Anlotinib, Placebo - Metastatic Colorectal Cancer | Phase 2 / Phase 3 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 419 | 2014-12-01 | 2019-05-21 |
Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1) · Leiomyosarcoma (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Sarcoma (1) · Sarcoma, Alveolar Soft Part (1) · Sarcoma, Synovial (1) · Uterine Cervical Neoplasms (1)
Advenchen Laboratories, LLC (2) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (2)
China (4) · Italy (2) · Spain (2) · United Kingdom (2) · United States (2) · South Korea (1)
Baohui Han, professor (1) · Jianqiang Cai, doctor (1) · Jinwan Wang, doctor (1) · Kai Lee, professor (1) · Yihebali Chi, doctor (1)
PMID 30032842, PMID 30098152, PMID 30392239, PMID 31689797, PMID 32077550, PMID 32944404, PMID 37185961